gastroparesis symptoms glp-1 Your patient took semaglutide this week. Cancel the EGD, proceed, or risk-stratify? The OCULUS randomized trial found clinically significant residual gastric volume was higher when GLP-1/GIP agonists were continued vs held for Ozempic & the Gut: What

Susie Massie, ND Are you a healthcare practitioner

Its a totally normal experience: General consensus is that most people will gain 5-7 pounds during the perimenopause transition through early menopause

Supplementation prior to exercise or sporting events has been shown to increase athletic performance by 11%

Semaglutide at the 2.4 mg dose (the maximum approved for weight management) produces roughly 15-17% body weight reduction in clinical trials

10.1016/j.tem.2009.11.007 142

Furthermore, C16-carnitine may influence the functionality of vascular endothelial cells by interacting with the endothelial cell differentiation gene-1 receptor, resulting in the accumulation of Ca 2+ within the cells [123]